Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
Clinical trial NCT07435779 · RECRUITING
Trial details
- NCT number
- NCT07435779
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-04
- Primary completion
- 2027-02-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.